These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 15033381)
21. Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex. Devoto P; Flore G; Saba P; Frau R; Gessa GL Brain Behav; 2015 Oct; 5(10):e00393. PubMed ID: 26516613 [TBL] [Abstract][Full Text] [Related]
22. Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study. Mateo Y; Fernández-Pastor B; Meana JJ Br J Pharmacol; 2001 Aug; 133(8):1362-70. PubMed ID: 11498523 [TBL] [Abstract][Full Text] [Related]
23. Noradrenergic terminals are the primary source of α Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147 [TBL] [Abstract][Full Text] [Related]
24. Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex. Invernizzi RW; Parini S; Sacchetti G; Fracasso C; Caccia S; Annoni K; Samanin R Br J Pharmacol; 2001 Jan; 132(1):183-8. PubMed ID: 11156576 [TBL] [Abstract][Full Text] [Related]
25. The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex. Pira L; Mongeau R; Pani L Eur J Pharmacol; 2004 Nov; 504(1-2):61-4. PubMed ID: 15507222 [TBL] [Abstract][Full Text] [Related]
26. High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex. Yoshitake T; Yoshitake S; Fujino K; Nohta H; Yamaguchi M; Kehr J J Neurosci Methods; 2004 Dec; 140(1-2):163-8. PubMed ID: 15589346 [TBL] [Abstract][Full Text] [Related]
27. Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep--wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. Léna I; Parrot S; Deschaux O; Muffat-Joly S; Sauvinet V; Renaud B; Suaud-Chagny MF; Gottesmann C J Neurosci Res; 2005 Sep; 81(6):891-9. PubMed ID: 16041801 [TBL] [Abstract][Full Text] [Related]
28. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan. de Boer TH; Nefkens F; van Helvoirt A; van Delft AM J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567 [TBL] [Abstract][Full Text] [Related]
29. Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors. Sacchetti G; Bernini M; Gobbi M; Parini S; Pirona L; Mennini T; Samanin R Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):66-72. PubMed ID: 11191838 [TBL] [Abstract][Full Text] [Related]
30. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082 [TBL] [Abstract][Full Text] [Related]
31. Effects of ketamine and pentobarbital on noradrenaline release from the medial prefrontal cortex in rats. Kubota T; Anzawa N; Hirota K; Yoshida H; Kushikata T; Matsuki A Can J Anaesth; 1999 Apr; 46(4):388-92. PubMed ID: 10232727 [TBL] [Abstract][Full Text] [Related]
33. The α₁-, but not α₂-, adrenoceptor in the nucleus accumbens plays an inhibitory role upon the accumbal noradrenaline and dopamine efflux of freely moving rats. Saigusa T; Aono Y; Uchida T; Takada K; Verheij MM; Koshikawa N; Cools AR Eur J Pharmacol; 2012 Aug; 688(1-3):35-41. PubMed ID: 22617026 [TBL] [Abstract][Full Text] [Related]
34. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Lapiz MD; Morilak DA Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081 [TBL] [Abstract][Full Text] [Related]
35. Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex. Jentsch JD; Wise A; Katz Z; Roth RH Synapse; 1998 Jan; 28(1):21-6. PubMed ID: 9414014 [TBL] [Abstract][Full Text] [Related]
36. Tyrosine administration does not affect desipramine-induced dopamine levels as measured in vivo in prefrontal cortex. Bongiovanni R; Kirkbride B; Walmire P; Jaskiw GE Brain Res; 2005 Aug; 1054(2):203-6. PubMed ID: 16083866 [TBL] [Abstract][Full Text] [Related]
37. Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus. Devoto P; Flore G; Saba P; Fà M; Gessa GL BMC Neurosci; 2005 May; 6():31. PubMed ID: 15865626 [TBL] [Abstract][Full Text] [Related]
38. Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats. Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T Eur J Pharmacol; 2004 Apr; 489(3):187-91. PubMed ID: 15087241 [TBL] [Abstract][Full Text] [Related]
39. The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis. Kawahara H; Kawahara Y; Westerink BH Eur J Pharmacol; 2001 Apr; 418(3):177-86. PubMed ID: 11343687 [TBL] [Abstract][Full Text] [Related]
40. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Swanson CJ; Perry KW; Koch-Krueger S; Katner J; Svensson KA; Bymaster FP Neuropharmacology; 2006 May; 50(6):755-60. PubMed ID: 16427661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]